View in EDS HTML Full Text

Patent Issued for Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood (USPTO 12208189).

Saved in:
Bibliographic Details
Title: Patent Issued for Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood (USPTO 12208189).
Source: Pharma Business Week. 2/18/2025, p1425-1425. 1p.
Database: Business Source Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: bsu
DbLabel: Business Source Ultimate
An: 183023617
AccessLevel: 2
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patent Issued for Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood (USPTO 12208189).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharma+Business+Week%22">Pharma Business Week</searchLink>. 2/18/2025, p1425-1425. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsu&AN=183023617
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 1425
    Titles:
      – TitleFull: Patent Issued for Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood (USPTO 12208189).
        Type: main
  BibRelationships:
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2/18/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 15436675
          Titles:
            – TitleFull: Pharma Business Week
              Type: main
ResultId 1